Treatment | Page 13 of 465 | SpiritIndia.com

Schizophrenia :: How schizophrenia develops, major clues discovered

Schizophrenia may occur, in part, because of a problem in an intermittent on/off switch for a gene involved in making a key chemical messenger in the brain, scientists have found in a study of human brain tissue. The researchers found that the gene is turned on at increasingly high rates during normal development of the prefrontal cortex, the part of the brain involved in higher functions like thinking and decision-making — but that this normal increase may not occur in people with schizophrenia.

Cancer :: Cancer death rate decline doubling in US, says CDC

A new report from the nation’s leading cancer organizations shows cancer death rates decreased on average 2.1 percent per year from 2002 through 2004, nearly twice the annual decrease of 1.1 percent per year from 1993 through 2002.

Diabetes :: PGC-1-alpha helps skeletal muscle and pancreatic islets communicate

Some individuals with type 2 diabetes (which is characterized by abnormally high blood glucose levels) have lower than normal amounts of the protein PGC-1-alpha in their skeletal muscles, but it is not known whether this has a role in the onset of diabetes or if it is caused by the diabetes.

Cancer :: Improving cancer patients’ psychosocial care

State-of-the-art detection and treatment have contributed to the ongoing decline in the cancer death rate in the United States. But most cancer patients do not receive care that addresses the psychological and social problems that frequently accompany cancer and its treatment.

Colorectal Cancer :: ImClone & Bristol-Myers Squibb with Merck KGaA to develop Erbitux in Japan

ImClone Systems Incorporated (Nasdaq: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) announced that they have established an agreement with Merck KGaA for the co-development and co-commercialization of ERBITUX(R) (cetuximab) in Japan.

HIV :: FDA approves new HIV drug raltegravir tablets

The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.

Epilepsy :: Once-a-day epilepsy drug is effective for partial seizures

The epilepsy drug lamotrigine is effective in controlling partial seizures when taken once a day as an added therapy, according to a study published in the October 16, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology.

Acupuncture :: Acupuncture reduces pain, need for opioids after surgery

Using acupuncture before and during surgery significantly reduces the level of pain and the amount of potent painkillers needed by patients after the surgery is over, according to Duke University Medical Center anesthesiologists who combined data from 15 small randomized acupuncture clinical trials.

Sleep Apnea :: Usage of CAM therapies high among those with obstructive sleep apnea hypopnea syndrome

A high proportion of patients with obstructive sleep apnea hypopnea syndrome (OSAHS) report previous or current use, and interest in future use, of complementary and alternative medicine (CAM) therapies, according to a study published in the October 15 issue of the Journal of Clinical Sleep Medicine (JCSM).

HIV :: Many Africans don’t continue HIV AIDS treatment

More than one-third of patients receiving HIV medication in Africa die or discontinue their treatment within two years, according to a study published in PLoS Medicine.